Valuation: Star Scientific, Inc.

Market Cap 2L 1L 1L 1L 2L 1.46Cr 2L 14.63L 6L 72.9L 6L 6L 2.44Cr P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 2Cr 1.74Cr 1.62Cr 1.49Cr 2.81Cr 191.02Cr 2.85Cr 19Cr 7.49Cr 95Cr 7.52Cr 7.35Cr 318.88Cr EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%-3.12%+51.15%+150.58% 1,03000Cr
+0.21%-1.13%+53.26%+46.92% 62TCr
-2.51%-2.33%+32.56%+66.35% 45TCr
+0.06%+1.17%+36.21%+31.25% 35TCr
-0.14%-0.83%+33.24%+40.28% 30TCr
-0.69%-0.44%+9.86%+14.23% 27TCr
-7.37%-4.31%-5.69%-41.99% 23TCr
-0.64%+3.68%+27.80%+62.95% 21TCr
-0.82%-0.50%+13.46%+69.41% 16TCr
Average -1.12%+4.83%+27.98%+48.89% 40.14TCr
Weighted average by Cap. -0.72%+4.87%+36.61%+70.85%

Financials

2014 2015
Net sales - -
Net income -3.85Cr -3.35Cr -3.12Cr -2.86Cr -5.4Cr -367.69Cr -5.49Cr -37Cr -14Cr -183.05Cr -14Cr -14Cr -613.8Cr -68.45L -59.5L -55.38L -50.85L -96.03L -65Cr -97.51L -6.53Cr -2.56Cr -33Cr -2.57Cr -2.51Cr -109.08Cr
Net Debt -45T -39.12T -36.41T -33.43T -63.13T -42.96L -64.11T -4L -2L -21.39L -2L -2L -71.71L 1.99Cr 1.73Cr 1.61Cr 1.48Cr 2.79Cr 189.56Cr 2.83Cr 19Cr 7.43Cr 94Cr 7.46Cr 7.29Cr 316.44Cr
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-